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Abstract 
 
The role of inositol 1,4,5-trisphosphate receptors (IP3Rs) in mediating Ca2+ mobilization in the 
adult heart is poorly understood. Moreover, whether these Ca2+ release channels are present 
and operative in human ventricular cardiomyocytes remains to be defined. IP3Rs may be 
activated after Gαq-protein–coupled receptor stimulation, affecting Ca2+ cycling, enhancing 
myocyte performance, and potentially favoring the occurrence of arrhythmic events. For this 
purpose, IP3R function was determined in left ventricular myocytes obtained from human 
hearts, and this analysis was integrated with assays in mouse myocytes to identify the 
mechanisms by which IP3Rs influence the electric and mechanical properties of the 
myocardium. We identified that IP3Rs are expressed and operative in human left ventricular 
myocytes. After Gαq-protein–coupled receptor activation, Ca2+ mobilized from the sarcoplasmic 
reticulum via IP3Rs contributes to the decrease in resting membrane potential, prolongation of 
the action potential, and occurrence of early afterdepolarizations. Ca2+ transient amplitude and 
cell shortening are enhanced, and extrasystolic and dysregulated Ca2+ elevations and 
contractions become apparent. These alterations in the electromechanical behavior of human 
cardiomyocytes are coupled with increased isometric twitch of the ventricular myocardium and 
arrhythmic events, suggesting that Gαq-protein–coupled receptor activation provides inotropic 
reserve, which is hampered by electric instability and contractile abnormalities. Additionally, our 
findings support the notion that increases in Ca2+ load by IP3Rs promote Ca2+ extrusion by 
forward-mode Na+/Ca2+ exchange, an important mechanism of arrhythmic events. In conclusion, 
the Gαq-protein/coupled receptor/IP3R axis modulates the electromechanical properties of the 
human myocardium and its propensity to develop arrhythmias. 
 
Keywords: cardiomyocytes, cardiac, electromechanical coupling, arrhythmias, calcium, inositol 
1,4,5-trisphosphate receptors. 
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List of Abbreviations 
 
2-APB, 2-aminoethyl diphenylborinate 
AP, action potential 
ATP, adenosine 5′-triphosphate 
DAG, diacylglycerol 
EAD, early after depolarization 
ER, endoplasmic reticulum 
ET-1, endothelin-1 
GPCR, Gαq-protein-coupled receptor 
IP3, inositol 1,4,5-triphosphate 
IP3R, inositol 1,4,5-triphosphate receptor 
LV, left ventricle 
NCX, Na+/Ca2+ exchanger;  
PKC, protein kinase C 
RMP, resting membrane potential 
RyR, ryanodine receptor 
SERCA, sarco-endoplasmic Ca2+ pump 
SR, sarcoplasmic reticulum 
XeC, xestospongin-C 
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Introduction 
The heart supplies blood to the whole body and this function is accomplished by the organized 
contraction of cardiac muscle cells. The mechanical activity is initiated by the electrical 
excitation of the myocardium, which acts as a functional syncytium in propagating membrane 
depolarization in cardiomyocytes (Joyner et al. 1983). The depolarization during the action 
potential (AP) leads to Ca2+ entry via voltage-activated L-type Ca2+ channel (Figure 1). This Ca2+ 
in turns triggers the translocation of this cation from the sarcoplasmic reticulum (SR) to the 
cytoplasm, a process termed Ca2+ induced-Ca2+ released (CICR, Fabiato, 1983). The resulting 
elevation in cytosolic Ca2+ (Ca2+ transient) promotes cross-bridge formation of the myofilament 
leading myocyte contraction (Bers, 2002). Subsequently, cytosolic [Ca2+] declines due to the re-
uptake into the SR via the Ca2+-ATPase (SERCA) and its extrusion via Na+/Ca2+ exchanger 
(NCX). This reduction allows Ca2+ to dissociate from the myofilaments and relaxation to occur 
(Bers, 2014). 
 
Figure 1. Excitation contraction coupling. Cartoon illustrating Ca2+ handling protein in 
cardiomyocytes. On right side, an action potential and corresponding Ca2+ transient obtained 
from a mouse left ventricular myocyte are reported (courtesy of Dr. Rota). 
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The repolarization phase of the AP is a critical determinant of the kinetics of Ca2+ entry since it 
controls the pattern of Ca2+ influx via L-type channels (ICaL) and NCX, in a time and voltage 
dependent manner (Rota et al. 2007; Signore et al. 2013). Thus, transmembrane Ca2+ fluxes 
and CICR modulate the temporal dynamic of [Ca2+]i, providing an important link between 
electrical activity, on the one hand, and myocyte and myocardial contractility and relaxation, on 
the other. 
In the heart, myocytes located in different anatomical regions present typical AP characteristics 
due to the differential expression of a variety of voltage-gated ion channels. The AP profile of 
left ventricular (LV) myocytes is composed of five phases (Figure 2): the rapid depolarization 
phase (phase 0, the upstroke) driven by the influx of Na+ ions via fast activating/inactivating 
channels (INa); the early repolarization phase (phase 1), mediated by fast activation of the 
transient outward K+ currents (Ito and the ultra-rapid IKur); the plateau phase (phase 2), which is 
maintained by the balance of inward 
currents (ICaL and late Na
+ current, INaL), 
outward K+ currents (delayed rectifier, 
IKr and IKs) and NCX; the late 
repolarization phase (phase 3) is 
mediated by continuous K+ efflux by 
delayed rectifier and inward rectifier 
(IK1) currents. Phase 4 is the resting 
membrane potential, which is 
maintained by inward rectifier K+ 
conductance, together with NCX and 
the Na/K-ATPase. Phase 4 
corresponds to cellular diastole. 
 
Figure 2. Action potential waveform 
and underlying ionic currents in 
adult ventricular myocyte. Adapted 
from Nerbonne & Kass, 2005. 
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Myocytes located in pacemaker regions are characterized by the ability to generate a 
progressive membrane depolarization during diastole, which smoothly transition into phase 1, 
mainly mediated by Ca2+ influx. Although mechanisms related to diastolic depolarization are not 
fully agreed upon, ion channels and Ca2+ released from the SR constitute, respectively, 
“membrane clock” and “calcium clock” responsible for the depolarization of sino-atrial nodal 
cells (Zaniboni et al. 2014; Maltsev & Lakatta, 2007). Important factors in determining the 
automaticity of pacemaker cells are represented by the lack of IK1 and by the presence of the 
funny current If, the latter allowing pacemaker cells to have a diastolic potential less negative 
with respect to the surrounding atrial myocytes. 
The electrophysiological characteristics of cardiomyocytes are species-dependent (Figure 4). 
Cells from large mammals and humans present long APs with prominent plateau. In contrast, 
small rodents have a short AP lacking the plateau phase. These properties are caused by the 
different expression and conductance of the various ion channels, resulting in dissimilar ionic 
current profile (Figure 4). Although the mechanism of excitation contraction (EC)-coupling is 
comparable in myocytes from large and small mammals, differences in the kinetics of Ca2+ 
transients are observed (see current results). Despite these factors, cells from human and 
rodent hearts present large similarities and, under pathological conditions, undergo comparable 
electromechanical adaptations. Typically, AP prolongation occurs in the failing human heart, a 
condition that is reiterated in experimental rodent models (Houser et al. 2000; Piacentino et al. 
2003; Steadman et al. 2011). 
Ca2+ is a ubiquitous intracellular signal that regulates different cellular functions, and has a 
central role in the physiology of the heart (Berridge et al. 2000). In human cardiac progenitor 
cells (hCPCs) Ca2+ release from the endoplasmic reticulum via inositol 1,4,5-triphosphate 
receptors (IP3Rs) promotes spontaneous Ca2+ oscillations. These events modulate cell cycle 
progression and the fate of hCPCs (Ferreira-Martins et al. 2009). Additionally, alterations of 
Ca2+ signals via IP3Rs controls apoptosis and commitment of differentiating embryonic stem 
cells (Liang et al. 2010). Although limited data in rodents and rabbits suggest that IP3Rs are 
expressed in left ventricular (LV) myocytes (Domeier et al. 2008; Harzheim et al. 2009), whether 
the presence of IP3Rs in primitive cells is preserved in the derived LV myocyte progeny playing 
a role in Ca2+ homeostasis remains to be defined. 
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Figure 3. Electrical properties of ventricular myocytes from different species. A, Action 
potentials recorded by patch-clamp in a mouse and dog cardiomyocytes. B, Action potential are 
shown at higher temporal resolution. C, A voltage-clamp command in the form of depolarizing 
and repolarizing ramps identifies differences in the ionic current profile in myocytes obtained 
from the two species. D, Micrographs illustrating mouse and dog  LV myocytes analyzed by 
patch-clamp (Signore and Rota, unpublished data).     
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Impaired IP3R-Ca2+ signaling and alterations of the calcineurin-NFAT pathway lead to 
developmental defects and abrogate cardiac hypertrophy induced by isoproterenol or 
angiotensin II (Nakayama et al. 2010; Uchida et al. 2010). Moreover, initial observations raise 
the possibility that enhanced IP3R activity may increase Ca2+ transient amplitude, the incidence 
of extra-systolic Ca2+ elevations and the propensity for arrhythmias (Harzheim et al. 2009). 
Dysfunctional RyRs result in spontaneous Ca2+ release or enhanced Ca2+ leak, pathologies 
found in inherited and acquired arrhythmogenic diseases (Houser, 2000; Wehrens et al. 2005; 
Knollmann et al. 2006; ter Keurs & Boyden, 2007; Herron et al. 2010), strengthening the notion 
that defects in Ca2+ homeostasis impact on the electrical properties of the heart. 
Thus, the hypothesis may be raised that abnormalities in Ca2+ transients in the presence of 
Gαq-protein-coupled receptors (GPCR) agonists may involve IP3R-mediated Ca2+ mobilization, 
cytoplasmic Ca2+ overload, perturbations in transmembrane potential, and/or sensitization of 
RyRs, leading to elementary release of Ca2+ and electrical instability. 
Ca2+ mobilized by IP3Rs relies on intracellular levels of IP3, which is produced by 
phospholipase C (PLC). GPCR agonists promote PLC function that generates IP3 and 
diacylglycerol (DAG). IP3 stimulates IP3Rs and Ca2+ translocation from intracellular stores 
(Ferreira-Martins et al. 2009; Berridge et al. 2000; Ferreira-Martins et al. 2012), whereas DAG 
activates transient receptor potential channels (TRPCs) (Hardie, 2007), and protein kinase C 
(PKC) isoforms, phosphorylating a wide spectrum of ion channels and contractile proteins 
(Steinberg et al. 1995; Braz et al. 2004; Mohácsi et al. 2004). Additionally, GPCR ligands may 
initiate PLC-independent signaling mechanisms, modulating transmembrane ionic fluxes 
(Mohácsi et al. 2004; Vassort et al. 2001). Thus, whether IP3Rs contribute to the functional 
consequences of GPCR stimulation in cardiomyocytes remains to be elucidated. 
Based on this premise, we have investigated the role of IP3Rs in human LV myocytes obtained 
from normal donor hearts not used from transplantation. This analysis in human cells was 
complemented with a number of assays in mouse myocytes to define the role of IP3Rs in Ca2+ 
mobilization, electrical activity, arrhythmic events, and myocyte contractile behavior following 
GPCR stimulation. 
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Materials and Methods 
Human Hearts and Myocyte Isolation 
In this study we employed donor hearts not used for transplantation and explanted failing hearts 
(Table 1). Donor and failing human hearts were shipped in cold cardioplegia solution, and were 
processed immediately upon receipt. 
 
Table 1: Human Samples 
 Gender N Age 
Human donor hearts 
Male 14 43.6 ± 5.9 
Female 20 48.8 ± 5.2 
Control human hearts (autopsies) 
Male 2 
62.3 ± 3.4 
Female 1 
Explanted end-stage failing hearts 
Male 8 49.0 ± 6.9 
Female 7 53.0 ± 3.8 
 
Myocardial samples, obtained at autopsy from patients who died from causes other than 
cardiovascular diseases, were fixed in formalin and used as controls for the quantitative 
evaluation of myocyte apoptosis by the terminal deoxynucleotidyl transferase assay. As 
previously performed in our laboratory (Goichberg et al. 2011) large LV myocardial samples 
were used; a branch of the left main coronary artery was cannulated and the distal arteries were 
ligated. Initially, the tissue was perfused with a solution containing (mmol/L): NaCl 126, KCl 4.4, 
MgCl2 5, HEPES 5, glucose 22, taurine 20, creatine 5, Na pyruvate 5, NaH2PO4 5, and 2,3-
butanedione monoxime 10 (pH 7.4, adjusted with NaOH). A constant temperature of 37°C was 
maintained, and the buffer was gassed with 85% O2 and 15% N2. After ~10 minutes, 0.015 
mmol/L CaCl2, 274 units/ml collagenase (type 2, Worthington Biochemical Corp), and 0.57 
units/ml protease (type XIV, Sigma) were added to the perfusate for enzymatic dissociation of 
the tissue. At completion of digestion, the myocardium was cut in small pieces, subjected to 
repeated pipetting to obtain a single cell preparation and re-suspended in Ca2+ 0.015 mmol/L 
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solution. Aliquots of cell suspensions were centrifuged for 5 minutes at 20g, and myocytes were 
frozen for biochemical assays. 
  
Mouse Hearts and Myocyte Isolation 
Female C57Bl/6 mice at ~3 months of age were used in this study. Animals were maintained in 
accordance with the Guide for Care and Use of Laboratory Animals, and all animal experiments 
were approved by the local animal care committee (Institutional Animal Care and Use 
Committees, IACUC). Mice were anesthetized with pentobarbital (50 mg/kg body weight, i.p.), 
the heart was excised and cannulated for retrograde perfusion through the aorta. A protocol 
similar to that described for the isolation of human cells was utilized here as well (Rota et al. 
2005; Rota et al. 2007; Signore et al. 2013). Isolated myocytes were suspended in Ca2+ 0.1 
mmol/L solution. For myocyte isolation, a protocol similar to that described above was employed 
(Rota et al. 2005; Rota et al. 2007). Antibodies for FACS analysis, and primers for PCR studies 
are listed in (Table 2) and (Table 3). 
 
 
 
Table 2: List of Antibodies 
Antigen Antibody Manufacturer 
sarcomeric α-actinin mouse monoclonal Sigma 
α-smooth muscle actin mouse monoclonal Sigma 
von Willebrand factor sheep polyclonal AbD Serotec 
PECAM-1 goat polyclonal R&D Systems 
procollagen 1α goat polyclonal Santa Cruz 
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Table 3: List of Primers 
Gene Primers 
Human IP3R type-1 
F: 5'- GAAGAGCACATCAAGGAAGAACAC -3' 
R: 5'- TGCTGACCAATGACATGGCT -3' 
Human IP3R type-2 
F: 5'- TAGTCCTGGTGAAAGTTAAAGACCC -3' 
R: 5'- CAGACTCATGGTCGATTCCAACT -3' 
Human IP3R type-3 
F: 5'- TGTACTTCATTGTGCTGGTCCG -3' 
R: 5'- CGAATCTCATTCTGCTCCCC -3' 
Mouse IP3R type-1 
F: 5'- GAGAGTTACGTGGCAGAGATGATC -3' 
R: 5'- GGCCAGAAAGATTGGTGACC -3' 
Mouse IP3R type-2 
F: 5'- TGTGGCATTACCTGTACTTCATCG -3' 
R: 5'- TCCGGATCTCATTTTGCTCAC -3' 
Mouse IP3R type-3 
F: 5'- CTGGAGCATAACATGTGGAACTACC -3' 
R: 5'- TGCAGGATGCGGATCTCATT -3' 
 
Cell Shortening and Ca2+ Transient Measurements in Isolated Myocytes 
Isolated LV myocytes were placed in a bath located on the stage of Axiovert (Zeiss), IX51 and 
IX71 (Olympus) inverted microscopes for measurements of contractility, Ca2+ transients and 
patch-clamp studies (Rota et al. 2005; Rota & Vassalle, 2003). Experiments were performed at 
room temperature. 
Cells were bathed continuously with a Tyrode solution containing (mmol/L): NaCl 140, KCl 5.4, 
MgCl2 1, HEPES 5, Glucose 5.5 and CaCl2 1.0 (pH 7.4, adjusted with NaOH). Measurements 
were performed in field-stimulated cells by using IonOptix fluorescence and contractility systems 
(IonOptix) and by video edge detection (Crescent Electronics). Contractions were elicited by 
rectangular depolarizing pulses, 2 ms in duration, and twice-diastolic threshold in intensity, by 
platinum electrodes (Rota et al. 2007). Cell shortening was measured by edge-track detection 
system (Rota et al. 2005; Rota et al. 2007). Changes in mean sarcomere length were computed 
13 
 
by determining the mean frequency of sarcomere spacing by fast Fourier transform, and then 
frequency data were converted to length. Ca2+ transients were measured by epifluorescence 
after loading the myocytes with 10 µml/L Fluo-3 AM (Invitrogen). Excitation length was 480 nm 
with emission collected at 535 nm using a 40x oil objective. Fluo-3 signals were expressed as 
normalized fluorescence (F/F0). Following treatment with IP3R modulators, some human 
myocytes were excluded from the analysis if prolonged contraction could not be discriminated 
from after-contraction during relaxation. Since in some experiments the effects of IP3R 
stimulation on myocyte contractility and cytoplasmic Ca2+ levels were measured simultaneously,  
the impact of the fluorescent Ca2+ sensitive dye on cell contraction was studied. When myocytes 
were loaded with Fluo-3, sarcomere shortening was significantly decreased with respect to non-
loaded cells (Figure 4). Thus, the weak contractile activity of myocytes throught the current 
study have to be evaluated in light of this specific experimental condition employed. 
 
Figure 4. Cell contractility and Ca2+ indicator Fluo-4. Sarcomere shortening in myocytes not 
loaded or following loading with the Ca2+ sensitive dye Fluo-4. Quantitative data are shown as 
mean±SEM. *P<0.05 versus Non-loaded Myocytes. 
 
 
 
 
 
Modulators of IP3R function included Gαq-protein 
coupled receptor agonists endothelin-1 (100 
nmol/L, Sigma), ATP (10 µmol/L, Sigma), 
angiotensin II (50 nmol/L, Sigma), phenylephrine 
hydrochloride (10 µmol/L, Sigma) (Gambassi et al. 1998; Pieske et al. 1999; Remus et al. 2006; 
Domeier et al. 2008; Gergs et al. 2008; Gonzalez et al. 2008; Higazi et al. 2009; Ferreira-
Martins et al. 2009; Harzheim et al. 2009; Nakayama et al. 2010; Ferreira-Martins et al. 2012). 
Additionally, thimerosal (10 µmol/L, Sigma) was utilized to enhance the affinity of IP3Rs to IP3 
(Ferreira-Martins et al. 2009; Ferreira-Martins et al. 2012; Bootman et al. 1992) IP3R function 
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was inhibited by exposing myocytes to xestospongin-C (2 µmol/L, Sigma) or 2-APB (2-
aminoethyl diphenylborinate, 10 µmol/L, Sigma); phospholipase-C activity was attenuated with 
U-73122 (2 µmol/L, Sigma) (Domeier et al. 2008; Higazi et al. 2009; Ferreira-Martins et al. 2009; 
Harzheim et al. 2009; Ferreira-Martins et al. 2012). PKC function was inhibited with 
chelerythrine (2 µmol/L, Sigma) (Dobson et al. 2008). RyR channels were blocked with 
ryanodine (10 µmol/L, MP Biomedicals) (Ferreira-Martins et al. 2009; Nett & Vassalle, 2003). 
 
Patch-Clamp Studies 
Data were acquired by means of the whole-cell patch-clamp technique in voltage and current-
clamp modes using Multiclamp 700A and 700B amplifiers (Molecular Devices). Electrical signals 
were digitized using 250 kHz 16-bit resolution A/D converters (Digidata 1322 and 1440A, 
Molecular Devices) and recorded using pCLAMP 9.0 and 10 software (Molecular Devices) with 
low-pass filtering at 2 kHz (Rota et al. 2005; Rota et al. 2007; Rota et al. 2007; Ferreira-Martins 
et al. 2009; Rota & Vassalle, 2003).  
For measurements of the action potential (AP), current-clamp mode was employed. Cells were 
stimulated with current pulses 1.5 times threshold. Myocytes were bathed with Tyrode solution 
as described above. The composition of the pipette solution was (mmol/L): NaCl 10, KCl 113, 
MgCl2 0.5, K2-ATP 5, glucose 5.5, HEPES 10 (pH 7.2 with KOH). The pipettes were pulled by 
means of a vertical (PB-7, Narishige) or horizontal (P-1000, Sutter Instrument) glass 
microelectrode pullers; when filled with intracellular solution pipettes had a resistance of 1-2 
MΩ. In Fluo-3 loaded myocytes, the fluorescence signal intensity was collected using a 
photomultiplier, and a photon to voltage converter (IonOptix) connected to the patch-clamp A/D 
converter (Rota et al. 2007). 
For electrophysiological and mechanical studies only rod-shaped myocytes exhibiting cross 
striations, and showing no spontaneous contractions or contractures were selected; cells were 
used within 12 hours following organ acquisition. 
IP3 dialysis in myocytes was achieved by whole-cell configuration patch-clamp, or by 
microinjection technique (FemtoJet, Eppendorf AG) in patch-clamped cells by dissolving 50 
µmol/L D-myo-Inositol 1,4,5-triphosphate potassium salt (Sigma) in the pipette solution 
(Ferreira-Martins et al. 2009; Hoesch et al. 2004).  
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For [Ca2+]i buffered conditions (Song et al. 1998), the pipette solution contained 10 mmol/L 
EGTA and 5 mmol/L CaCl2, which results in ~150 nmol/L free [Ca]i, calculated using 
Maxchelator program (http://www.stanford.edu/~cpatton/maxc.html). Membrane capacitance 
(Cm) was measured in voltage-clamp mode using a 5 mV voltage step and pCLAMP software 
algorithm (Rota et al. 2005; Rota et al. 2007; Rota et al. 2007; Ferreira-Martins et al. 2009; Rota 
& Vassalle, 2003). For action potential clamp (AP-clamp) assays, a set of AP waveforms were 
utilized as voltage-clamp commands in myocytes loaded with Fluo-3 AM (Rota et al. 2007). The 
2 solutions were similar to those utilized in current-clamp experiments. In the experiments in 
which RyRs were blocked, myocytes were initially incubated with 10 µmol/L ryanodine and then 
superfused with the same solution. To deplete Ca2+ from the SR, cells were incubated with 10 
µmol/L thapsigargin and 10 mmol/L caffeine (Sigma), and subsequently superfused and 
dialyzed with 5 µmol/L thapsigargin (Zaniboni et al. 1998; Zima et al. 2010) In these studies, 
myocytes were monitored for the absence of Ca2+ transients and/or cell shortening. Treatment 
with IP3R agonist was performed after the acquisition of baseline data.  
In excitation-contraction coupling (ECC) gain studies, Ca2+ current and Ca2+ transients were 
measured simultaneously in voltage-clamped myocytes (Rota et al. 2007). Cells were loaded 
with Fluo-3 AM and bathed with a modified Tyrode solution in which KCl was replaced with CsCl 
and 2 mmol/L 4-aminopyridine was added. The composition of the pipette solution was 
(mmol/L): NaCl 10, CsCl 113, MgCl2 0.5, Tris-ATP 5, glucose 5.5, HEPES 10 and 
tetraethylammonium chloride 20 (pH 7.2 with CsOH). Cells were depolarized for 300 ms from 
holding potential (Vh) -40 mV to a family of test potentials ranging from -30 to +70 mV. Each 
voltage-clamp was preceded by a train of 4 conditioning pulses (100 ms, 1Hz) from -40 to 0 mV 
(Rota et al. 2007).  
Contraction in patch-clamped myocytes was evaluated using ImageJ by reslice of the cell profile 
collected by videoclips and a CCD camera (Retiga EXi Fast 1394, QImaging). 
The nickel sensitive current was determined as follows: myocytes were bathed with a modified 
Tyrode solution in which KCl was replaced with CsCl; 10 µmol/L ryanodine and 4 µmol/L 
nicardipine were then added (Ozdemir et al. 2008). Pipette solution was identical to that used in 
ECC gain measurements. Following a 200 ms depolarization from -40 mV to +80 mV, a 
hyperpolarizing ramp 2 sec in duration was applied to reach -120 mV. The voltage-clamp 
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protocol was utilized in the absence and presence of 2.5 mmol/L NiCl2 in myocytes exposed to 
Tyrode, ATP, ET-1, or dialyzed by D-myo-IP3 salt. The nickel sensitive current was calculated 
as the difference between currents in the presence and absence of nickel.  
To establish the time course of Ca2+ transients evoked by depolarizing steps and by caffeine, 
myocytes were bathed with Tyrode solution under voltage-clamp. Ca2+ transients were elicited 
by voltage steps 50 ms in duration from Vh -70 mV to 0 mV, at 0.2 Hz. Every 2-4 min, a 20 
mmo/L caffeine spritz 0.5 sec in duration was delivered using a microinjector (FemtoJet, 
Eppendorf AG). Cells were studied in the absence or presence of ATP or ET-1. Analysis of Ca2+ 
transients was not extended to portion of recordings in which large inward currents (~>1 nA), 
potentially reflecting store-operated Ca2+ entry, were observed. 
 
In Vivo AAV9-shRNA-IP3R2-EGFP Vector Delivery 
To compromise IP3R type-2 expression in myocytes, an AAV9 vector carrying transgenic small 
hairpin-RNA targeting IP3R type-2 and EGFP (AAV9shRNA-IP3R2-EGFP, Vector Biolabs) was 
administered in twelve mice by intraventricular injections of 80 µl of solution containing the 
vector at titer of 8.8x10 (Gonzalez et al. 2008) VG/ml resuspended in PBS. Administration was 
performed in anesthetized mice (1.5% isoflurane) using a 32G needle Hamilton syringe. Mice 
were sacrificed 3 weeks after.  
Cardiomyocytes obtained from mice treated with AAV9-shRNA-IP3R2-EGFP vector were 
loaded with the Ca2+ indicator Rhod-2 (10 μmol/L; Invitrogen) (Ferreira-Martins et al. 2009; 
Ferreira-Martins et al. 2012). Excitation length was 545 nm with emission collected at 605 nm 
using a 40x objective. Rhod-2 signals obtained from EGFP-positive and EGFP-negative 
myocytes were expressed as normalized fluorescence (F/F0), where F0 is the diastolic 
fluorescent level subtracted by the background signal measured in the region adjacent to the 
cell. To establish whether the amplitude of Ca2+ transients was affected by the type of 
fluorescent Ca2+ indicator employed, mouse myocytes were loaded with Rhod-2, Fluo-4 (5 
μmol/L; Invitrogen), or a combination of the two dyes. Rhod-2 originated stronger diastolic, 
systolic, and background fluorescent signal, with respect to Fluo-4 (Figure 5A). However, 
kinetics of Ca2+ raise and decay were comparable, as shown by the normalized Ca2+ transient 
traces (Figure 5B). Importantly, when Ca2+ transient amplitude was expressed as ratio with 
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respect to diastolic Ca2+ level (F/F0),  Fluo-4 originated larger transient amplitude (Figure 5C). 
Importantly, previous work from our laboratory documented that EGFP does not interfere with 
detection of Rhod-2, by emission spectra analysis and intracellular Ca2+ measurements 
(Ferreira-Martins et al. 2009). 
 
 
 
Figure 5. Ca2+ indicators and Ca2+ transients in mouse myocytes. A, Ca2+ transient (black-
traces) in a myocyte loaded with the Ca2+ sensitive dyes Rhod-2 and Fluo-4; Ca2+ transient  was 
collected using the red fluorescent channel (emission wavelength 605 nm), and the green 
fluorescent channel (emission wavelength 535 nm). Background fluorescence was obtained in 
the region adjacent to the cell. Gray lines indicate portions of the recording reported in panel B. 
B, Ca2+ transients obtained with the red and green fluorescent channels are normalized by their 
amplitude and partly superimposed. C, Quantitative data for cells loaded with Rhod-2 or Fluo-4 
are shown as mean±SEM *P<0.05 versus Rhod-2. 
 
 
 
Quantitative RT-PCR 
Total RNA from isolated human and mouse LV myocytes, and mouse LV myocardium was 
extracted utilizing TRIZOL reagent (Invitrogen). cDNA was obtained from 1 µg total RNA in a 20 
µl reaction containing Reverse Transcription buffer (Applied Biosystems), 4 mmol/L each of 
dNTP together with 50 U of MultiScribe reverse transcriptase (Applied Biosystems), 20 U of 
RNase inhibitor (Applied Biosystems) and 5 µmol/L of oligo-(dT)15 primer. This mixture was 
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incubated at 37°C for 2 h. Subsequently, real-time RT-PCR was performed with primers 
designed using the Vector NTI Advance 11 (Invitrogen) software (Rota et al. 2007; Gonzalez et 
al. 2008). Sequences of primers are reported in (Table 3). The 7300 Real Time PCR system 
(Applied Biosystems) was employed for quantitative RT-PCR. In each case, 1 µl of cDNA was 
combined with Power SYBR Green Master Mix (Applied Biosystems) in a 20 µl reaction. Cycling 
conditions were as follow: 95°C for 10 min followed by 40 cycles of amplification (95°C 
denaturation for 15 sec, 60°C annealing and extension for 1 min). The melting curve was then 
obtained. To avoid the influence of genomic contamination, forward and reverse primers for 
each gene were located in different exons. PCR products were run on 2% agarose/1x TBE gel 
to confirm the specificity of the reaction. Total RNA extracted from human and mouse brain 
(Clontech) was employed as controls. 
 
Western Blotting 
Whole cell protein extracts from cell pellets of isolated human or mouse myocytes were 
prepared using RIPA buffer (Sigma), supplemented with a cocktail of protease inhibitors 
(Roche) and phosphatase inhibitors (Sigma). Equivalent of 50 µg of proteins were separated on 
4 to 20% SDS-PAGE, transferred onto PVDF membrane, blocked with 5% BSA and exposed to 
the following primary antibodies: rabbit polyclonal IP3R type-2 (Cell Signaling), rabbit polyclonal 
IP3R type I/II/III (Santa Cruz Biotechnology), mouse GAPDH (Millipore) followed by horseradish 
peroxidase-conjugated secondary antibodies (Cell Signaling Technology and Jackson 
ImmunoResearch Laboratories), and developed using Pierce SuperSignal West Femto 
Maximum Sensitivity Chemiluminescent Substrate (Fisher Scientific). IP3R expression was 
normalized by GAPDH. 
 
Two-Photon Microscopy 
Myocytes were loaded with 10 µmol/L Fluo-3 AM (Invitrogen) and placed on the stage of a two-
photon microscope (BX51WI Olympus microscope coupled with a Bio-Rad Radiance 2100MP 
system). Cells were bathed with a Tyrode solution, and field stimulated using platinum 
electrodes. Fluo-3 was excited at 900-960 nm wavelength with mode-locked Ti:sapphire 
femtosecond laser (Tsunami, Spectra-Physics), and the emission signal was collected at 535 
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nm. Images were acquired in line scan mode with a 2 ms sampling rate (Ferreira-Martins et al. 
2009). 
 
Isometric Force in Human Trabeculae Carneae 
Thin LV trabeculae were dissected from the LV wall and mounted in a horizontal tissue bath 
(Steiert, Hugo Sachs Elektronik-Harvard Apparatus) connected to a force transducer (F10, 
Harvard Apparatus). Muscles were superfused with Krebs–Henseleit buffer (KHB; Sigma), 
containing in mmol/L: 118 NaCl, 4.7 KCl, 11 glucose, 1.2 MgSO4, 1.2 KH2PO4, 1.8 CaCl2 and 25 
NaHCO3 gassed with 95% O2/5% CO2 (pH 7.4) at 37°C. Tissue was stimulated by two platinum 
electrodes using field stimulation from an isolated stimulator output (frequency 0.5 Hz; impulse 
duration 2 ms; intensity 1.5-fold threshold). Each muscle was stretched to the length at which 
force of contraction was maximal. The developed tension was measured isometrically with the 
force transducer attached to a Bridge Amp (ADInstruments) and a 4 kHz A/D converter (Power 
Lab 4/30, ADInstruments). Contractile signal was recorded using LabChart 7 Pro software 
(ADInstruments). Muscle preparations were allowed to equilibrate for at least 60 min. The effect 
of ATP (100 µmol/L), endothelin-1 (100 nmol/L), and isoproterenol (100 nmol/L, Sigma) on 
developed tension, is expressed as fold change with respect to baseline values obtained in the 
absence of these agonists. 
 
Ex-vivo Electrical Properties of Human and Mouse Myocardium 
Human LV samples and mouse hearts were perfused, respectively, through a large branch of 
the left coronary artery and the aorta in a Langendorff apparatus at a constant pressure of 80 
mm Hg with KHB solution (Goichberg et al. 2011). The temperature was maintained at 37°C by 
immersing the myocardial tissue in a water-heated glassware reservoir (Radnoti), containing 
preheated KHB. Human myocardium and mouse hearts were stimulated with a 2 ms square 
pulse at two-times its threshold level (4 channels stimulator, BMS 414, Crescent Electronics), 
using a mini-coaxial electrode (Harvard Apparatus). Myocardial electrical activity was monitored 
employing a two-lead mini ECG system (Harvard Apparatus) in which electrodes were placed 
on the endocardial and epicardial aspects of the human LV sample, or on the right atrium and 
apex of the mouse heart. Monophasic action potentials (MAPs) were recorded using a micro 
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MAP-Tip electrode (Harvard Apparatus) (Goichberg et al. 2011). ECG and MAP signals were 
amplified (Animal Bio Amp, ADInstruments), digitized using a 4 kHz A/D converter (Power Lab 
8/30, ADInstruments) and recorded using LabChart 7 Pro software (ADInstruments) with low 
and high-pass filtering at 1 kHz and 0.3 Hz, respectively. A protocol of programmed electrical 
stimulation (PES) was used to assess the propensity of mouse hearts to develop ventricular 
arrhythmias (Goichberg et al. 2011; Roell et al. 2007). PES consisted of a train of pacing stimuli 
(S1) applied at 150 ms cycle length, with an extra stimulus (S2) inserted every eighth beat. The 
S1-S2 interval was progressively reduced until the S2 stimulus either failed to generate an 
action potential or induced arrhythmic events. The appearance of ventricular tachycardia (3 or 
more consecutive ectopic beats characterized by atria-ventricular dissociation) and/or 
ventricular fibrillation was established (Goichberg et al. 2011). ATP (20 µmol/L), ET-1 (100 
nmol/L), and thimerosal (20 µmol/L) were used to promote IP3R function. In a subset of 
experiments, 10 µmol/L glibenclamide was employed to block IKATP, a repolarizing current 
activated under ischemic conditions (Pandit et al. 2011). 
 
Data Analysis 
The magnitude of sampling employed in each measurement is listed in Appendix. Data are 
presented as mean±SEM. Independent samples were compared using ANOVA analysis with 
Bonferroni correction or Fisher’s exact tests, as appropriate for continuous or categorical 
responses. The normality and homogeneity of variance of the data were checked first to meet 
the assumptions of ANOVA. Paired observations were evaluated with Wilcoxon signed-rank 
sum test or paired t-test as appropriate.  For data with multiple measurements (myocytes) from 
the same donor (mouse/patient), linear mixed-effects models with patient/mouse as random 
effect, main effects for treatment group were applied to examine and compare response 
changes. The compound symmetry covariance matrix was specified to account for dependency 
among observations. Differences in mean changes between assessments were compared 
between groups and within each group by LSMEANS statement. Throughout, a P<0.05 was 
considered statistical significance and all tests were two sided with a type I error of 0.05. The 
statistical analyses were performed using SAS version 9.3 (SAS Institute) (Berenson et al. 
1988). 
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Results 
Human Hearts 
Human cardiomyocytes were obtained from the LV of 34 donor hearts declined from 
transplantation; 14 males and 20 females, with an average age of 44±4 years (Table 1). In 
donor hearts, foci of replacement fibrosis and areas of diffuse interstitial fibrosis were not 
detected histologically. Myocyte apoptosis was comparable in three randomly selected donor 
hearts and age-matched control hearts obtained at autopsy from patients who died from causes 
other than cardiovascular diseases (Figure 6). Thus, myocyte survival in donor hearts was not 
affected by the preservation protocol, which involved cardioplegic solution. End-stage failure in 
explanted hearts was of ischemic (n=6) and non-ischemic (n=9) origin. 
 
Figure 6. Myocyte death. Myocyte 
apoptosis measured by TdT-
labeling in control hearts obtained 
from 3 randomly selected donor 
hearts not used for transplantation 
and 3 age-matched control hearts 
collected at autopsy. Results are 
shown as mean±SEM. 
 
 
IP3Rs, Ca2+ Transients, and Human Myocyte Contractility 
Ca2+ release from the ER via IP3Rs originates cytosolic Ca2+ oscillations in human cardiac 
progenitor (Ferreira et al. 2009), raising the possibility that these channels are preserved and 
functional in adult cardiomyocytes. Thus, we established whether IP3Rs are expressed in 
human LV myocytes and whether their function modulates Ca2+ cycling and contractility in this 
cell compartment. This analysis was integrated with assays in mouse cells. Molecular studies 
were conducted in isolated myocyte preparations with minimal levels of contamination from 
fibroblasts, endothelial cells and smooth muscle cells, as established by immunocytochemistry 
and FACS analysis (Figure 8). Transcripts for the three IP3R subtypes were identified by qRT-
PCR in human LV myocytes (Figure 8A and Figure 9). The expression of IP3R type-2 was also 
confirmed by Western blotting (Figure 8B). Similarly, the presence of IP3Rs in mouse LV 
myocytes was documented by both methodologies (Figure 10 and Figure 11).  
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Figure 7. Human and mouse cardiac cells. A, Myocytes, fibroblasts, smooth muscle cells and 
endothelial cells were identified by α-sarcomeric actinin (sc α-actinin, red dots), procollagen-1α 
(purple dots), α-smooth muscle actin (α-SMA, blue dots), and von Willebrand factor (vWF, 
human; green dots) or PECAM-1 (mouse, green dots), respectively. Black dots correspond to 
negative control. B, Fraction of cardiomyocytes (CMs), fibroblasts (Fbs), smooth muscle cells 
(SMCs), and endothelial cells (ECs) in human and mouse myocyte preparations. Results are 
shown as mean±SEM. 
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Figure 8. IP3Rs in human cardiomyocytes. A, qRT-PCR show transcripts for the three IP3R 
subtypes in human LV myocytes. Representative curves and PCR products are shown together 
with the mRNA obtained from the human brain, that was used as positive control (red curves). 
The PCR products had the expected molecular weight. Human β2-microglobulin: housekeeping 
gene (for sequences see Figure 9). B, Expression of IP3R protein by Western blotting in human 
LV myocytes with IP3R-2 and pan-IP3R antibodies, respectively. GAPDH: loading condition. 
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Figure 9. Sequences of human transcripts. Nucleotide sequences were obtained in a sense 
and anti-sense direction to confirm the specificity of the amplified PCR products for human 
genes.   
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Figure 10. IP3Rs in mouse cardiomyocytes. A, qRT-PCR show transcripts for the three IP3R 
subtypes in mouse LV myocytes. Representative curves and PCR products are shown together 
with the mRNA obtained from the mouse brain, that was used as positive control (red curves). 
The PCR products had the expected molecular weight. MW: molecular weight. For sequences 
see Figure 11. B, Expression of IP3R protein by Western blotting in mouse LV myocytes with 
IP3R-2 and pan-IP3R antibodies, respectively. GAPDH: loading condition. 
 
Figure 11. Sequences of mouse transcripts. Nucleotide sequences were obtained in a sense 
and anti-sense direction to confirm the specificity of the amplified PCR products for mouse 
genes.  
26 
 
The effect of IP3R activation on Ca2+ cycling and contractility of human LV myocytes was 
investigated by stimulating GPCRs with adenosine 5′-triphosphate (ATP) and endothelin-1 (ET-
1), which both enhance the activity of PLC, and the synthesis of IP3 and DAG (Ferreira-Martins 
et al. 2009; Domeier et al. 2008; Harzheim et al. 2009; Nakayama et al. 2010; Ferreira-Martins 
et al. 2012; Pieske et al. 1999; Remus et al. 2006; Gergs et al. 2008). ATP increased myocyte 
contractility, and this response was attenuated with the unspecific IP3R blocker 2-APB (Figure 
12A). The enhanced cell performance mediated by GPCR activation was coupled with an 
increase in Ca2+ transient amplitude (Figure 12B). Inhibition of IP3Rs with the selective blocker 
xestospongin-C (XeC) did not modify baseline myocyte mechanics, but abrogated the changes 
mediated by GPCR stimulation (Figure 12C).  
The increase in contractility with these agonists led to episodes of after-contractions during 
relaxation in 27% of human cardiomyocytes; however, spontaneous and sustained Ca2+ 
elevations were observed rarely (Figure 13A-13C).  
The effects of GPCR activation on cardiomyocytes were equally present in myocardial 
trabeculae dissected from the LV wall. ATP and ET-1 enhanced isometric developed tension, 
which was abolished by IP3R antagonists 2-APB and XeC (Figure 14). Thus, IP3R inhibition in 
human cardiomyocytes and myocardium attenuates the positive inotropic action of GPCR 
stimulation. 
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Figure 12. IP3Rs, Ca2+ cycling, and contractility in human cardiomyocytes. A, Sarcomere 
shortening in a field stimulated human cardiomyocyte, exposed first to ATP (10 µmol/L) and 
then to the IP3R blocker 2-APB (10 µmol/L). Higher time resolution traces are shown in the 
inset. B, Ca2+ transients (red-traces) and sarcomere shortening (black-traces) in a field 
stimulated cardiomyocyte before (Tyrode) and after exposure to ET-1 (100 nmol/L). C, 
Quantitative data for Fluo-loaded cells are shown as mean±SEM. Tyr: Tyrode; XeC: 
xestospongin-C (2 µmol/L). *P<0.05 versus Tyr, †P<0.05 versus ET-1.  
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Figure 13. IP3Rs, Ca2+ cycling, and contractility in human cardiomyocytes. A. After-
contractions (arrowheads) in a LV myocyte exposed to ATP. B, Fraction of myocytes, 27%, with 
impaired relaxation (black portion of the bar). *P<0.05 versus Tyr. C, Ca2+ transients (red-
traces) and sarcomere shortening (black-traces) in field stimulated cardiomyocyte exposed to 
ATP. An ectopic (arrows) and sustained Ca2+ elevation coupled with prolonged contraction is 
shown.  
 
 
Figure 14. IP3Rs, Ca2+ cycling, and contractility in human cardiomyocytes. A, Isometric 
tension in human LV trabeculae exposed to ATP (100 µmol/L) and then to the IP3R blocker 2-
APB. B, Quantitative data are shown as mean±SEM. Base: baseline in the presence of Krebs-
Henseleit buffer. *P<0.05 versus Base.  
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GPCRs and Electrical Instability 
To establish whether the electrical properties of human cardiomyocytes were influenced by 
activation of GPCRs, membrane potential and [Ca2+]i were measured simultaneously in current-
clamped cells loaded with the Ca2+ indicator Fluo-3. In human cardiomyocytes, ATP and ET-1 
decreased resting membrane potential (RMP), prolonged the action potential (AP), and 
promoted the occurrence of early after-depolarizations (EADs), together with an increase in 
Ca2+ transient amplitude and extra-systolic Ca2+ elevations. Comparable responses were 
observed with the IP3R agonist, thimerosal (Figure 15).  
Importantly, ATP and ET-1 had similar effects on the intact myocardium. Human samples were 
perfused in a Langendorff apparatus, and transmural pseudo-ECG and monophasic action 
potentials (MAPs) were recorded. GPCR agonists ET-1 and ATP delayed the electrical recovery 
and prolonged MAPs (Figure 16A, and 16B), mimicking the observations at the myocyte level.  
Moreover, tachycardia and premature ventricular contractions occurred (Figure 16C). To 
exclude the contribution of ischemia, potentially introduced during the preservation of the organ, 
measurements were obtained in the presence of KATP channel blockade, since these channels 
are activated by hypoxia. Inhibition of KATP channels had no consequences on MAPs (Figure 
17), indicating that the electrical manifestations dictated by GPCR stimulation were independent 
from myocardial ischemia. Thus, GPCR stimulation prolongs the AP and promotes the electrical 
instability of cardiomyocytes and the myocardium. 
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Figure 15. IP3Rs and electrical properties of human cardiomyocytes. A, APs (black-traces) 
and Ca2+ transients (red-traces) in a human myocyte exposed to ATP. In the lower panel, traces 
are shown at higher time resolution. B, AP (black-traces) and Ca2+ transients (red-traces) in a 
human myocyte before and after ET-1 exposure. C, EADs (black-traces) and Ca2+ transients 
(red-traces) of human myocytes with ATP, ET-1, and the IP3R-agonist, thimerosal (10 µmol/L).  
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Figure 15. IP3Rs and electrical properties of human cardiomyocytes (continued). D, 
Quantitative data are shown as mean±SEM. *P<0.05 versus Tyr. 
  
32 
 
 
 
 
Figure 16. IP3Rs and electrical properties of human myocardium. A, ET-1 prolongs the 
electrical activation (pseudo-ECG, red-traces) and the AP (black-traces) of paced human 
myocardium. B, Quantitative data are shown as mean±SEM. Base: Krebs-Henseleit buffer. 
*P<0.05 versus Base. C, Premature-ventricular-contractions (PVCs; red-arrowheads) and 
triggered-activity (red-dashed-lines) in human myocardium with ET-1 and ATP (20 µmol/L). 
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Figure 17.  Monophasic action potentials and IKATP activation. Quantitative data for human 
LV tissue perfused in a Langendorff system indicate the minimal effects of the IKATP blocker 
glibenclamide (10 µmol/L) on repolarization time. Data are shown as mean±SEM. Base: Krebs-
Henseleit buffer. 
 
GPCR Simulation in the Failing Human Heart 
Contractile reserve is severely reduced in heart failure (HF), and the GPCR/IP3R axis may 
represent an important signaling pathway modulating the inotropic state of the diseased 
myocardium. Thus, explanted failing hearts were studied (Table 1). By Western blotting, IP3R-2 
expression was significantly increased in failing LV myocytes (Figure 18A). Importantly, 
stimulation of GPCRs with ATP in failing LV myocytes led to a reduction in RMP and 
prolongation of the AP (Figure 18B). Similarly, measurements of cell shortening in one failing LV 
cardiomyocyte revealed that this GPCR/IP3R activation increased contractility, elicited 
premature contraction and altered relaxation (Figure 18C). 
The effects of GPCR stimulation on the myocardium were evaluated in an isometric system. In 
comparison with donor human hearts, the inotropic response of LV trabeculae to the β-
adrenergic agonist isoproterenol was significantly attenuated in failing hearts (Figure 19A). In 
contrast, GPCR stimulation promoted an increase in developed tension in the diseased 
myocardium mimicking the findings obtained in healthy hearts (Figure 14 and Figure 19B). 
Thus, the inotropic reserve is decreased in the failing heart muscle, while the GPCR/IP3R axis 
remains operative.     
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Figure 18. IP3Rs and GPCR activation in the failing human myocardium. A, Expression of 
IP3R-2 protein by Western blotting in normal and failing human LV myocytes. GAPDH: loading 
condition. Quantitative data are shown as mean±SEM. *P<0.05 versus Normal Hearts. B, APs 
of a failing human myocyte before (black-trace, Tyr) and after (blue trace) exposure to ATP. 
Quantitative data are shown as mean±SEM. Tyr: Tyrode; *P<0.05 versus Tyr, using paired t-
test. C, Cell shortening in a field stimulated human failing cardiomyocyte, before and following 
exposure to ATP. Arrow and arrowhead point to a premature contraction and altered relaxation, 
respectively. 
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Figure 19. Contractile reserve of the failing human myocardium. A and B, Quantitative 
data for isometrically twitching human LV trabeculae. Data are shown as mean±SEM. Iso: 
isoproterenol (100 nmol/L); Base: baseline in the presence of Krebs-Henseleit buffer. *P<0.05 
versus Base, †P<0.05 versus Normal Heart in the presence of Iso. 
 
IP3Rs and Mouse Cardiomyocytes  
To define the role of IP3Rs in myocyte contractility following GPCR activation, a loss of function 
assay was introduced in LV mouse cardiomyocytes. Initial studies were performed to 
demonstrate that GPCRs agonists induce in mouse cardiomyocytes responses similar to those 
seen in human cells. ATP, ET-1, angiotensin II or phenylephrine stimulation led to an increase 
in Ca2+ transient amplitude and myocyte contractility. Diastolic Ca2+ was also elevated. Extra-
systolic Ca2+ and sustained Ca2+ increases were apparent, resulting in after-contractions and 
prolonged contractures, respectively (Figure 20). Increased IP3R affinity by thimerosal led to 
comparable results. In contrast, IP3R blockade (XeC) or inhibition of IP3 synthesis (U-73122) 
abolished the effects of GPCR stimulation (Figure 20D-20F).  
By employing two-photon microscopy working in line-scan mode, it was possible to demonstrate 
that extra-systolic Ca2+ and sustained increases in peak Ca2+ were distributed synchronously in 
the myocyte cytoplasm; this pattern of Ca2+ changes excludes that local releases of Ca2+ from 
the SR, or Ca2+ waves were involved in the process (Figure 21). 
ATP and ET-1 may stimulate other effector pathways involving phosholipase-C (PLC), which 
activates PKC isoforms, resulting in the phosphorylation of ion channels and contractile proteins 
(Steinberg et al.1995; Braz et al. 2004; Mohácsi et al. 2004). To establish whether this 
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mechanism was implicated in myocyte performance, studies in mouse LV myocytes were 
conducted in the presence of the PKC inhibitor chelerythrine (Dobson et al. 2008). Chelerythrine 
failed to abrogate the inotropic response triggered by ATP and ET-1 (Figure 22) suggesting that 
PKC-independent pathways play a critical role in mediating the impact of GPCR stimulation in 
myocytes. 
 
Figure 20.  IP3Rs, Ca2+ transients and contractility in mouse myocytes. A, Ca2+ transients 
(red-traces), sarcomere shortening (black-traces), extra-systolic Ca2+ elevations and after-
contraction in a field stimulated myocyte in the presence of ET-1. B, Effects of ATP (10 µmol/L), 
angiotensin II (Ang II, 50 nmol/L), phenylephrine (Phe, 10 µmol/L), and thimerosal (Thi, 10 
µmol/L) on extra-systolic Ca2+ elevations (red-traces) and after-contractions (black-traces) in 
myocytes.  
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Figure 20.  IP3Rs, Ca2+ transients and contractility in mouse myocytes (continued). C, ET-
1 and ATP induce spontaneous sustained Ca2+ elevations and contracture in myocytes. D, IP3R 
blockade with xestospongin-C (XeC, 2 µmol/L) prevents largely the effects of ET-1 on Ca2+ 
transients (red-traces) and myocyte contractility (black-traces).  
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Figure 20.  IP3Rs, Ca2+ transients and contractility in mouse myocytes (continued). E, 
Quantitative data are shown as mean±SEM *P<0.05 versus Tyr. Tyr: Tyrode; Base: baseline 
prior to IP3R stimulation. F, Fraction of myocytes with extra-systolic and sustained Ca2+ 
elevations (black portion of the bars). *P<0.05 vs. Tyr, †P<0.05 versus ATP or ET-1.  
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Figure 21.  Ca2+ changes in 
mouse myocytes. Normal Ca2+ 
transients (upper), extra-systolic 
(center), and sustained Ca2+ 
elevations (lower) are distributed 
uniformly throughout the length of 
stimulated myocytes. Line scan 
images were acquired by two-
photon microscopy in myocytes 
loaded with Fluo-3 (green). Traces 
from the line-scan mode are shown 
below each image.  
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Figure 22. Inhibition of PKC does not abrogate the effects of GPCR activation on mouse 
myocytes. A, Quantitative data are shown as mean±SEM *P<0.05 versus Tyr or Base. Tyr: 
Tyrode; Base: baseline prior to IP3R stimulation; Che, chelerythrine (2 µmol/L). B, Fraction of 
myocytes with after-contractions and sustained contractures (black portion of the bars). *P<0.05 
versus Tyr or Base.  
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Based on this information, which strengthened the human results, the consequences of 
downregulation of IP3R type-2 on Ca2+ cycling in myocytes was tested using a small hairpin-
RNA (sh-RNA) assay. An adeno-associated AAV9 vector carrying EGFP and sh-RNA targeting 
IP3R type-2 (shRNA-IP3R2-EGFP) was injected intravenously in mice (Figure 23). Three weeks 
later, EGFP-positive and EGFP-negative LV myocytes were isolated (Figure 24) and loaded 
with the Ca2+ indicator Rhod-2. Ca2+ transient was measured in field stimulated cells, in the 
absence and presence of ATP or ET-1. GPCRs activation failed to increase Ca2+ transients in 
EGFP-positive mouse myocytes. Similarly, extra-systolic and sustained Ca2+ elevations were not 
detected. Conversely, these responses were preserved in EGFP-negative cells (Figure 26). 
Electrophysiologically, the effects of GPCR stimulation in mouse myocytes were similar to those 
observed in human cells. Activation of GPCR function with ATP or ET-1, or enhanced IP3R 
affinity by thimerosal decreased RMP, prolonged the AP, and increased the frequency of EADs 
in mouse myocytes. Ca2+ transient amplitude increased, and extra-systolic Ca2+ elevations were 
apparent (Figure 26). Similarly, spontaneous sustained depolarization to the plateau and long-
lasting [Ca2+]i increases were detected (Figure 27). Importantly, direct activation of IP3Rs by 
dialysis with IP3 in the myocyte cytoplasm had effects comparable to those seen with GPCR 
agonists or thimerosal (Figure 28). IP3R blockade, in the absence of GPCR agonists, did not 
alter the AP, Ca2+ transients and myocyte contractility (Figure 29). Conversely, IP3R inhibition 
reversed the effects of ET-1 and ATP on cardiomyocytes (Figure 30).  
Electrical abnormalities similar to those observed in isolated myocytes were detected in the 
perfused mouse heart under conditions favoring IP3R function; the arrhythmic events triggered 
by regular pacing and programmed electrical stimulation were markedly enhanced (Figure 31).  
Thus, IP3Rs mediate partly the effects of GPCR stimulation on Ca2+ cycling and the electrical 
and mechanical properties of adult human and mouse cardiomyocytes. 
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Figure 23. Downregulation of IP3Rs. Transcripts for IP3R 
type-2 are downregulated in the LV myocardium of mice 
injected with an adeno-associated AAV9 vector carrying EGFP 
and small hairpin-RNA targeting IP3R type-2 (shRNA-IP3R2).  
 
 
Figure 24. Downregulation of IP3Rs, Ca2+ transients, and extra-systolic Ca2+ elevations. A, 
Left panel: EGFP-negative myocyte (arrowheads) and EGFP-positive myocyte (arrows); the 
EGFP-positive myocyte is shown again by native EGFP fluorescence in the right panel. These 
myocytes were collected from a mouse heart treated with AAV9 vector carrying EGFP and 
shRNA targeting IP3R-2. B, Ca2+ transients in EGFP-negative (black-traces) and EGFP-positive 
myocytes (green-traces) in the presence of ATP and ET-1. C, Fraction of myocytes with extra-
systolic and sustained Ca2+ elevation (black portion of the bars). Quantitative data are shown as 
mean±SEM. *P<0.05 versus Tyr. †P<0.05 versus EGFP-negative myocytes.  
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Figure 25. GPCR activation and Ca2+ transient in mouse myocytes. ATP and ET-1 induce 
sustained elevations of Ca2+ in EGFP-negative mouse myocytes with preserved expression of 
IP3R type 2. Cells were obtained from the LV myocardium of mice injected with an adeno-
associated AAV9 vector carrying EGFP and small hairpin-RNA targeting IP3R type-2 (shRNA-
IP3R2); myocytes were loaded with the Ca2+ sensitive dye Rhod-2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. IP3R activation in mouse myocytes. A, Transmembrane potential (black-traces) 
and Ca2+ transients (red-traces) in current-clamped myocytes before and after exposure to ET-1 
(upper traces), ATP (middle traces), and thimerosal (lower traces). IP3R stimulation results in 
prolongation of the AP and in EADs, which are coupled with increased Ca2+ transient and extra-
systolic Ca2+ elevations.  
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Figure 26. IP3R activation in mouse myocytes (continued). B, Quantitative data are shown 
as mean±SEM. *P<0.05 versus Tyr. C, Fraction of myocytes with EADs (black portion of the 
bars). *P<0.05 versus Tyr.  
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Figure 27. GPCR activation 
and myocyte function. A, 
Sustained membrane 
depolarization of the AP in 
human (upper black-trace) and 
mouse (lower black-trace) 
cardiomyocytes with ET-1 is 
associated with intracellular 
Ca2+ elevations (lower red 
trace). B, Fraction of mouse 
myocytes with sustained 
depolarizations (black portion 
of the bars). *P<0.05 versus 
Tyr.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Downregulation of IP3Rs, Ca2+ transients, and extra-systolic Ca2+ elevations. A, 
Electrical (black-traces) and Ca2+ transient (red-traces) properties of myocytes dialyzed with IP3 
(50 µmol/L, phase-contrast micrograph). B, Quantitative data are shown as mean±SEM. 
*P<0.05 versus Base, using paired t-test.  
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Figure 29. IP3R blockade in mouse myocytes. A, Electrical (black-traces) and Ca2+ transient 
(red-traces) properties of a mouse myocyte before and after blockade of IP3Rs with 2-APB (10 
µmol/L). B and C, Quantitative data are shown as mean±SEM. *P<0.05 versus Tyr.  
 
 
Figure 30. Effects of activation and blockade of IP3Rs on mouse myocytes. A, 
Transmembrane potential (black-traces) and Ca2+ transients (red-traces) in a mouse myocyte 
exposed to ATP and then to the IP3R blocker 2-APB. Prolonged APs and sustained 
depolarizations coupled with the increase in Ca2+ transient amplitude are induced by ATP and 
are reversed by 2-APB. Circles indicate portions of the traces shown at higher time resolution in 
the inset.  
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Figure 30. Effects of activation and blockade of IP3Rs on mouse myocytes (continued). 
B, Transmembrane potential (black-traces) and Ca2+ transients (red-traces) in a mouse myocyte 
exposed to ET-1 and then to the IP3R blocker 2-APB. ET-1 prolonged the AP, and induced 
spontaneous depolarization and EADs coupled with increased Ca2+ transient amplitude; these 
effects were reversed by 2-APB. Circles indicate portions of the traces shown at higher time 
resolution in the inset.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. IP3Rs alter the electrical activity of the mouse heart. A, IP3R activation and 
arrhythmia (red-dashed-lines) of the mouse heart with pacing (upper-traces), or programmed 
electrical stimulation (PES; lower-traces). B, Fraction of mouse hearts showing arrhythmic 
episodes (black portion of the bars). Ctrl: Krebs-Henseleit buffer. *P<0.05 versus Ctrl.  
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GPCR stimulation and Ca2+ Release from RyRs 
The increase in Ca2+ transient amplitude and extra-systolic Ca2+ elevations induced by GPCR 
agonists in myocytes may result from the prolongation of the AP and altered repolarization 
phase. Alternatively, Ca2+ mobilized by IP3Rs may sensitize RyRs, enhancing excitation 
contraction-coupling gain and promoting spontaneous Ca2+ releases, which, in turn, may affect 
myocyte electrical properties (Harzheim et al. 2009). 
To establish the role of the AP profile on the properties of Ca2+ transients following GPCR 
stimulation, AP-clamp studies were performed (Sah et al. 2001, Rota et al. 2007). AP 
waveforms were recorded in Tyrode solution (Ctrl-APs) or with GPCR agonists (GPCR-APs). 
Subsequently, these AP waveforms were employed as voltage-clamp commands, while 
monitoring intracellular Ca2+ in myocytes loaded with the Ca2+ indicator Fluo-3. Despite GPCR 
stimulation, Ctrl-APs were characterized by physiological Ca2+ transients with no extra-systolic 
Ca2+ elevations (n=23/23) (Figure 32-33). Conversely, GPCR-APs showed increased Ca2+ 
transients in the presence (n=27/27) or absence (n=8/8) of GPCR agonists (Figure 32-34). 
These experiments under voltage-clamp indicate that the alterations in Ca2+ transients observed 
following GPCR stimulation are secondary to changes in AP profile.  
To test whether RyRs were sensitized by GPCR activation, Fluo-3 loaded myocytes were 
exposed to a family of depolarizing steps in voltage-clamp mode to progressively activate L-type 
Ca2+ current (ICaL) and release of Ca
2+ from RyRs (Gomez et al. 2001, Pott et al. 2005, Rota et 
al. 2007). ICaL, Ca
2+ transient amplitude, and the ability of Ca2+ influx to induce RyR-Ca2+ release 
(excitation contraction-coupling gain) did not change with activation of GPCRs (Figure 35).  
These results tend to exclude the possibility that the release of Ca2+ following activation of 
IP3Rs enhances the sensitivity of RyRs.  
To establish whether RyRs contribute to the changes in the electrical properties of myocytes 
after GPCR stimulation, these Ca2+ channels were blocked by ryanodine (Nett & Vassalle, 2003; 
Ferreira-Martins et al. 2009) and the effects of ATP were studied. Under this condition, Ca2+ 
transients and myocyte shortening were inhibited (Figure 36); however, RMP decreased, the AP 
was prolonged, and arrhythmic events occurred (Figure 37).  
These findings suggest that RyRs are not implicated in the electrical instability of 
cardiomyocytes mediate by GCPR activation. 
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Figure 32. The profile of the AP conditions the effects of GPCR activation on Ca2+ 
transients, and IP3R activation does not alter ryanodine receptor function. A and B, APs 
(Vmembrane: membrane potential, black-traces) and Ca
2+ transients (Fluo-3, red-traces) in a 
mouse cardiomyocyte exposed to ET-1. APs with variable profiles were recorded in current-
clamp mode (A) before (Ctrl-AP) and after activation of GPCRs (GPCR-AP) and used as 
voltage-clamp commands (Vcommand, blue-traces) (B); Ca
2+ transients (red-traces) and 
membrane currents (black-traces) are shown.  
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Figure 33. The profile of the AP conditions the effects of GPCR activation on Ca2+ 
transients. A and B, APs (Vmembrane: membrane potential, black-traces) and Ca
2+ transients 
(Fluo-3, red-traces) in a mouse cardiomyocyte exposed to ATP. APs with variable profiles were 
recorded in current-clamp mode (A) before (Ctrl-AP) and after activation of GPCRs (GPCR-AP) 
and used as voltage-clamp commands (Vcommand, blue-traces) (B); Ca
2+ transients (red-traces) 
and membrane currents (black-traces) are shown.  
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Figure 34. The profile of the AP conditions the effects of GPCR activation on Ca2+ 
transients. APs (black-traces) and Ca2+ transients (red-traces) in a myocyte exposed to ET-1 
(left); the recorded APs were employed as IP3R-APs command (blue-traces) in a myocyte 
(right) kept in Tyrode solution.  
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Figure 35. The effects of GPCR activation on Ca2+ transients, and IP3R activation does 
not alter ryanodine receptor function. A, ICaL (black-traces) and Ca
2+ transients (red-traces) 
elicited by depolarizing steps (blue-traces) by patch-clamp in the presence of ET-1 and ATP. B, 
Voltage relations for ICaL, Ca
2+ transient amplitude and ECC gain in Tyr and after IP3R 
stimulation.  
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Figure 36. Effects of RyR blockade on Ca2+ cycling and contractility of mouse myocytes. 
A and B, Depolarizing steps in voltage-clamp mode (A and B, black traces) elicit Ca2+ transients 
(A, red traces) and cell shortening (B, reslice image) in a mouse myocyte in Tyrode solution. 
Long-lasting depolarizations to 0 mV (black traces, arrows) lead to Ca2+ elevations (A) and 
localized contractions in the form of waves (B). Higher time resolution traces and images are 
shown in the right panels. C and D, In the presence of ryanodine (10 µmol/L), depolarizing steps 
in voltage-clamp mode do not induce Ca2+ transients (C, red traces) and contractions (D, reslice 
image). Long-lasting depolarizations to 0 mV (arrows, black traces) generate small increases in 
intracellular Ca2+ (C) in the absence of waves of contraction (D, reslice image). Higher time 
resolution traces and images are shown in the right panels.  
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Figure 37. The effects of GPCR activation on Ca2+ transients, and IP3R activation does 
not alter ryanodine receptor function. A, Transmebrane potential (black traces) and cytosolic 
[Ca2+]i (red traces) in myocytes exposed to ryanodine before and after ATP stimulation. B, 
Effects of IP3R activation on the AP following blockade of RyRs (ryanodine, 10 µmol/L). 
Quantitative data are shown as mean±SEM. *P<0.05 versus ryanodine alone. C, IP3R 
activation and arrhythmic events. Transmembrane potential (black-trace) and cytosolic Ca2+ 
(red-trace) in a current-clamped mouse myocyte exposed to thimerosal in the presence of 
ryanodine. Blockade of RyRs did not prevent spontaneous sustained depolarizations.  
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IP3Rs and Electrical Properties Following GPCR Stimulation 
Although GPCR stimulation prolongs the AP favoring an increase in Ca2+ transients, the 
mechanism(s) involved in the changes of the electrical activity of cardiomyocytes have not been 
defined as yet. Based on the fact that (a) IP3 dialysis or (b) enhanced IP3R affinity to IP3 
recapitulate the effects of GPCR stimulation, and that (c) IP3R downregulation or (d) IP3R 
inhibition attenuate the effects of ATP and ET-1, the possibility was raised that mobilization of 
Ca2+ from the SR by IP3Rs contributes to the altered electrical properties of myocytes in the 
presence of GPCR agonists. Ca2+ translocation from the SR may enhance cytosolic Ca2+ load, 
which may promote Ca2+ extrusion via forward mode NCX; this process may contribute to the 
depolarization of the RMP, and the delayed repolarization phase of the AP (Spencer & Sham, 
2003; Armoundas et al. 2003). 
To test this hypothesis, voltage-clamp studies were performed in myocytes loaded with Fluo-3. 
IP3R function led to elevations in diastolic Ca2+ that were followed by sustained and transient 
inward currents. Importantly, the increase in diastolic Ca2+ developed slowly over a period of 
several seconds, potentially reflecting IP3R-mediated Ca2+ release (Figure 38A). The changes 
in resting Ca2+ and inward currents were preserved, despite inhibition of RyRs (Figure 38B). 
Conversely, blockade of the NCX prevented inward currents in the presence of increased 
cytosolic Ca2+ (Figure 38C). 
To define the role of NCX following activation of IP3Rs, a nickel sensitive current, indicative of 
NCX activity, was measured (Ozdemir et al. 2008). ATP, ET-1, and dialysis with IP3 induced 
large inward currents, consistent with enhanced Ca2+ extrusion via forward mode NCX (Figure 
39).  
Additionally, to strengthen the possibility that Ca2+ extrusion was enhanced following Ca2+ 
mobilization by IP3Rs, myocytes were voltage-clamped at -70 mV; Ca2+ transient was triggered 
by short depolarizing steps and caffeine puffs to monitor intracellular SR Ca2+ stores. In the 
presence of ATP or ET-1, this protocol resulted in a gradual decrease in Ca2+ transients (Figure 
40), supporting the notion that Ca2+ leak occurs under conditions favoring IP3R function. 
To test whether the mobilization of Ca2+ from the SR via IP3Rs was implicated in the 
prolongation of the AP, decreased RMP, and increased EADs, Ca2+ from the SR was depleted 
by inhibition of SERCA and exposure to caffeine (Zaniboni et al. 1998; Zima et al. 2010). By this 
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approach, ATP and ET-1 showed a markedly reduced effect on RMP, AP duration, and 
arrhythmia (Figure 41). Additionally, to establish the impact of increased Ca2+ load on the 
electrical instability of cardiomyocytes, these cells were studied under [Ca2+]i buffered 
conditions, to prevent changes in cytosolic Ca2+ (Song et al. 1998). GPCR agonists had no 
effects on RMP and AP (Figure 42). Collectively, these observations indicate that Ca2+ 
mobilization from the SR via IP3Rs contributes to the alterations in the electrical properties of 
cardiomyocytes mediated by GPCR stimulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. IP3Rs activate the NCX through changes in [Ca2+]i. (See next page) A, Transient 
and sustained inward currents (black-traces) and slowly developing diastolic [Ca2+]i elevations 
(red-traces) in mouse myocytes exposed to thimerosal. Membrane potential was held at -70 
mV; short (5 ms) depolarizing steps to 0 mV were used to trigger Ca2+ transients. The Ca2+ 
fluorescent signal is reported at higher magnification in the lower traces. B, Transient and 
sustained inward currents (black-traces) and slowly developing [Ca2+]i elevations (red-traces) in 
mouse myocytes held at -70 mV following exposure to ATP and ryanodine. C, Slowly 
developing diastolic [Ca2+]i elevations (red-traces) in a mouse myocytes exposed to ATP and 
ryanodine in the presence of nickel (2.5 mmol/L), fail to induce transient and sustained inward 
currents (black-traces). Membrane potential was held at -70 mV; short (5 ms) depolarizing steps 
to 0 mV were employed.  
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Figure 39. IP3R stimulation and NCX function. Current voltage relations for the nickel (Ni)-
sensitive current measured in voltage-clamp in the absence of IP3R stimulation and in the 
presence of ATP, ET-1, or IP3 dialysis (left). On the right, superimposed curves indicate that the 
Ni-sensitive current is enhanced following IP3R stimulation. To prevent RyR-Ca2+ release, 
ryanodine was employed.  
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Figure 40. GPCR stimulation and SR Ca2+ release in voltage-clamped myocytes. A, Ca2+ 
transients elicited by depolarizing steps from -70 to 0 mV, and by caffeine (20 mmol/L) puffs 
(arrows) in mouse myocytes in the absence (upper traces) and presence of ATP (lower traces). 
Δ indicates the time interval between traces displayed on the left and right panel. B, Changes in 
Ca2+ transient amplitude over time for myocytes exposed to Tyrode (Tyr) or GPCR agonists 
(ATP or ET-1). Quantitative data are shown as mean±SEM. *P<0.05 versus Tyr, using paired t-
test.  
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Figure 41. The effects of GPCR activation on mouse myocytes are abolished by depletion 
of Ca2+ from the SR. A, Transmembrane potential in mouse myocytes exposed to ATP in 
control conditions (upper trace) or following depletion of SR Ca2+ (lower trace). Thapsigargin (10 
µmol/L), TG. B, Quantitative data are shown as mean±SEM. *P<0.05 versus Tyr.  
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Figure 41. The effects of GPCR activation on mouse myocytes are abolished by depletion 
of Ca2+ from the SR (continued). C, Transmembrane potential in mouse myocytes exposed to 
ET-1 in control conditions (upper trace) or following depletion of SR Ca2+ (lower trace). 
Thapsigargin, TG. D, Quantitative data are shown as mean±SEM. *P<0.05 versus Tyr 
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Figure 42. The effects of GPCR activation on mouse myocytes are abolished by 
intracellular Ca2+ buffered condition.  In the presence of buffered [Ca2+]i, ATP and ET-1 fail to 
alter the myocyte AP profile. Quantitative data are shown as mean±SEM.  
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Discussion 
The results of the current study provide a characterization of the electrical and mechanical 
properties of human LV myocytes and emphasize the critical role that the GPCR/IP3R axis has 
in regulating Ca2+ homeostasis, contractile performance and the electrical stability of the human 
heart. IP3Rs are expressed and functional in human LV myocytes, and the Ca2+ mobilized from 
the SR by IP3Rs contributes to the decrease in RMP, prolongation of the AP, and to the 
occurrence of EADs and sustained depolarizations following GPCR stimulation. Ca2+ transient 
amplitude and cell shortening are enhanced, and extra-systolic and dysregulated Ca2+ 
elevations and contractions become apparent. These alterations in the electromechanical 
behavior of human cardiomyocytes are coupled with increased isometric twitch of the 
myocardium and arrhythmic events, indicating that the GPCR/IP3R effector pathway offers 
inotropic reserve, which is hampered by electrical instability and contractile abnormalities. 
IP3Rs are present in primitive cells of the fetal and adult heart (Ferreira-Martins et al. 2009, 
Ferreira-Martins et al. 2012). However, the growth promoting effects of IP3Rs in progenitor cells 
are lost in post-mitotic human cardiomyocytes (Kockskämper et al. 2008). In both cases, IP3Rs 
modulate the release of Ca2+ from the SR, but its distal effect varies dramatically; the increase in 
cytosolic Ca2+ favors cell cycle reentry and asymmetric division of fetal progenitor cells 
(Ferreira-Martins et al. 2009), while, as shown here, the release of Ca2+ in adult human 
cardiomyocytes enhances cell contractile performance. Whether a link between these two 
distinct mechanisms actually exists is currently unknown, although IP3Rs have a critical 
independent biological function in these two different cell types. 
The contribution of IP3Rs to the electromechanical behavior of ventricular myocytes in small 
and large mammals is controversial (Domeier et al. 2008; Kockskämper et al. 2008). Our 
findings support the notion that in the human heart IP3Rs represent an important substrate able 
to increase myocyte contractility and the propensity for electrical instability coupled with GPCR 
agonists. Increases in the circulating levels of neurohumoral transmitters and cytokines 
physiologically and pathologically (Francis et al. 1993; Molkentin, 2000) may involve IP3R 
activation predisposing the heart to arrhythmic events. The increased incidence of arrhythmias 
and sudden death in patients with chronic heart failure (Huikuri et al. 2001; Rubart & Zipes, 
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2005) may be related partly to upregulation of IP3Rs in the hypertrophied, dysfunctional 
cardiomyocytes (Del Monte & Hajjar, 2008; Houser & Margulies, 2003).  
The GPCR agonists ATP and ET-1 stimulate IP3Rs in human cardiomyocytes, but other 
signaling pathways may be upregulated as well. These GPCR agonists activate PLC that 
generates not only IP3 but also DAG, which activates TRPCs and PKC isoforms (Hardie, 2007; 
Mohácsi et al. 2004). PKC phosphorylates ion channels and myofilament proteins, affecting the 
electrical and mechanical properties of cardiomyocytes (Steinberg et al. 1995; Braz et al. 2004; 
Mohácsi et al. 2004). Additionally, ATP and ET-1 may enhance  PLC-independent molecular 
events (Mohácsi et al. 2001; Vassort, 2001), which may trigger transmembrane ionic fluxes. 
Importantly, the effects of ATP and ET-1 on myocyte contractility were maintained in the 
presence of a PKC inhibitor. Similarly, the alterations in the electrical properties of 
cardiomyocytes were recapitulated by direct stimulation with IP3 or by enhancing IP3R affinity. 
Conversely, the effects of GPCR agonists were abrogated by: (a) downregulation of IP3Rs; (b) 
inhibition of IP3R function or reduced IP3 production; (c) depletion of Ca2+ from the SR; and (d) 
buffered intracellular Ca2+. Collectively, our data support the notion that the Ca2+ mobilized by 
IP3Rs is a critical determinant of the electrical abnormalities dictated by stimulation of GPCRs. 
However, we cannot exclude that DAG-sensitive and PLC-independent signaling pathways may 
participate in the electromechanical changes initiated by IP3R function. GPCR agonists 
modulate ICaL and the delayed rectifier K
+ currents, which can alter the AP profile (Mohácsi et al. 
2001; Vassort, 2001). Moreover, changes in membrane potential may result from TRPCs and 
store-operated Ca2+ channels activated, respectively, by DAG and SR Ca2+ levels (Hardie, 
2007; Parekh & Putney, 2005). 
A significant issue concerned whether, following GPCR stimulation, Ca2+ mobilization from the 
SR via IP3Rs alters the electrical properties of myocytes directly, or indirectly by Ca2+ release 
from RyR channels (Domeier et al. 2008; Harzheim et al. 2009). The contribution of RyRs to the 
process was analyzed by combining Ca2+ imaging with electrophysiological measurements. Our 
findings indicate that IP3Rs contribute to the alteration of the AP, independently from an 
increase in sensitivity of the RyRs. Excitation contraction-coupling gain was preserved in the 
presence of GPCR agonists, documenting that RyR function was not enhanced by the changes 
in Ca2+.  
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Despite inhibition of RyRs, cytosolic Ca2+, NCX forward mode, and electrical abnormalities 
increased in LV myocytes following stimulation of the GPCR/IP3R axis. Collectively, the 
cascade of events initiated by GPCR ligands involves promotion of PLC enzymatic activity, IP3 
production, opening of IP3R channels, and Ca2+ translocation from the SR to the cytoplasm. 
The latter favors the electrogenic extrusion of this cation via NCX, resulting in depolarization of 
the RMP and prolonged repolarization of the AP (see catoon in Figure 43).  
These electrical changes positively impact on the process of Ca2+ induced Ca2+ release since 
the delayed repolarization of the AP sustains Ca2+ influx, amplifying Ca2+ transients and cell 
shortening (Sah et al. 2001, Rota et al. 2007). By AP-clamp, remodeled APs, in the absence of 
GPCR ligands, elicited Ca2+ transients comparable to those associated with GPCR agonists. 
These findings indicate that the altered electrical activity has a critical role in the process, rather 
than suggesting a direct interaction between IP3R and RyR function. Moreover, the enhanced 
Ca2+ entry by the protracted AP may counteract the excess of Ca2+ extruded during diastole via 
NCX, restoring intracellular SR Ca2+ stores. This may account for the prolonged effects of IP3R 
in the presence of GPCR agonists. Conversely, with stable (time constrained) depolarizations in 
voltage-clamp, GPCR agonists are coupled with a progressive decrease in Ca2+ transient 
amplitude and SR Ca2+ load, emphasizing the importance that the changes in the AP profile 
have in mediating a sustained positive inotropic effect. 
The extra-systolic elevations in Ca2+ and after-contractions detected in cardiomyocytes with 
GPCR agonists appear to be due to EADs, which may be the product of the alteration in the AP 
(Rubart & Zipes, 2005). In fact, changes in AP profile alone were sufficient to trigger alone 
extra-systolic Ca2+ elevations, pointing to the alterations in the electrical properties of 
cardiomyocytes as the primary mediator of Ca2+ cycling abnormalities. However, the ionic basis 
for the sustained membrane depolarization, protracted Ca2+ increases and myocyte 
contractures remains to be completely defined. IP3-independent effector pathways may 
participate in the process, although the cellular alterations were abrogated by attenuating IP3R 
function.  
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Figure 43. Excitation-contraction coupling and GPCR stimulation in myocytes. A, 
Schematic representation of the process of Ca2+-induced Ca2+ release under physiological 
conditions. During the AP (1), Ca2+ enters the cell via L-type channels, triggering the opening of 
RyRs and release of Ca2+ from the SR (2), which originates a cytosolic Ca2+ transient (3). B, 
Signaling cascade initiated by GPCR activation. Ligand-GPCR interaction (1) promotes PLC 
enzymatic activity (2), leading to the formation of soluble IP3 (3). The latter triggers the opening 
of IP3Rs and Ca2+ translocation from the SR to the cytoplasm (4). The increased cytoplasmic 
Ca2+ load (5) induces the electrogenic extrusion of this cation (6); this phenomenon results in 
depolarization of the RMP, protracted repolarization of the AP, and the occurrence of EADs (7). 
The remodeled profile of the AP leads to a sustained Ca2+ influx and potentiated Ca2+ release 
via RyRs (8), enhancing Ca2+ transients (9). Extra-systolic Ca2+ elevations are coupled with 
EADs.  
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The spatiotemporal dynamics of Ca2+ mobilized by IP3Rs is dictated by the hierarchical 
recruitment of elementary Ca2+ release when [IP3]i is increased; this condition originates Ca
2+ 
blips, puffs, and global regenerative waves (Berridge et al. 2000). In the absence of GPCR 
agonists, blockade of IP3R channels has little or no impact on the mechanical and electrical 
behavior of cardiomyocytes, indicating that extracellular activators of PLC are needed to 
increase [IP3]i and trigger an IP3R response. As in other cell types (Ferreira-Martins et al. 2009; 
Berridge et al. 2000; Ferreira-Martins et al. 2012), IP3R activation results in a time-dependent 
increase in cytosolic Ca2+ of cardiomyocytes that develops slowly over a number of seconds. 
With GPCR agonists, the temporal dynamic of IP3R-mediated Ca2+ release provides the basis 
for the sustained changes in the AP, cellular contractility, and incidence of electrical disorders. A 
similar sequence of events appears to be operative in failing human cardiomyocytes, in which 
IP3R transcripts (Go et al. 1995) and proteins are up-regulated, providing a potential etiology for 
arrhythmias and sudden death in this patient population. 
Ca2+ release channels are differentially expressed during cardiac development and postnatally 
(Kockskämper et al. 2008; Gorza et al. 1997; Janowski et al. 2010); in cardiomyocytes, the 
contribution of the ubiquitous IP3R to intracellular Ca2+ mobilization is progressively attenuated 
from the fetal to the neonatal and adult life, in favor of the more specialized function of RyRs 
(Kockskämper et al. 2008; Janowski et al. 2010). Thus, the up-regulation of IP3Rs may be 
viewed as a component of a larger fetal reprogramming in the failing myocardium, together with 
the multiple pathological changes that characterize the progression of the disease state. 
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Appendix 
 
 
Magnitude of Sampling 
 
 Parameter Experimental Condition n Figure 
Mouse myocytes 
Sarcomere 
shortening 
Non-loaded myocytes 27 
Fig 4 
Fluo-loaded myocytes 13 
Mouse myocytes Ca2+ transients 
Rhod-2 69 
Fig 5 
Fluo-4 62 
Human tissue Myocyte apoptosis 
Control Hearts (Autopsy) 3 
Fig 6 
Donor Hearts 3 
Human myocytes Sample Composition FACS 5 Fig 7 
Mouse myocytes Sample Composition FACS 5 Fig 7 
Human myocytes 
Ca2+ transients, 
sarcomere 
shortening 
Tyrode (Tyr) 23 
Fig 12-B, 
Fig 13-B 
ATP 9 
ET-1 6 
XeC 9 
ET-1+XeC 3 
Human LV trabecuale 
Isometric force 
(paired analysis) 
ATP 18 
Fig 14-B ET-1 14 
ATP+XeC 4 
Human myocytes 
Current-clamp, 
Ca2+ transients 
(paired analysis) 
ATP 
11, 
8 
Fig 15-D 
ET-1 6, 4 
Thimerosal 6, 4 
Perfused human LV Monophasic action ATP 7 Fig 16-B 
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myocardium (paired 
analysis) 
potential (MAP), 
EKG 
ET-1 4 
Glibenclamide 2 Fig 17 
Human myocytes 
Western blotting, 
IP3R-2 expression 
Normal Hearts 5 
Fig 18-A 
Failing Hearts 5 
Failing human 
myocytes 
Current-clamp ATP 4 Fig 18-B 
Human LV trabecuale 
Isometric force 
(paired analysis) 
Isoproterenol, Normal 
Hearts 
10 
Fig 19-A 
Isoproterenol, Failing 
Hearts 
6 
Failing human LV 
trabecuale 
Isometric force 
(paired analysis) 
ATP 12 
Fig 19-B 
ET-1 10 
Mouse myocytes 
Ca2+ transients, 
sarcomere 
shortening 
(paired analysis) 
ATP 8 
Fig 20-E 
ET-1 8 
AngII 9 
Phenylephrine (Phe) 10 
Thimerosal 14 
ATP in the presence of 
XeC 
7 
ET-1 in the presence of 
XeC 
7 
ET-1 in the presence of U-
73122 
8 
Ca2+ transients, 
sarcomere 
Tyrode (Tyr) 144 
Fig 20-F 
ATP 21 
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shortening ET-1 29 
AngII 15 
phenylephrine (Phe) 21 
Thimerosal (Thi) 14 
ATP in the presence of 
XeC 
49 
ATP in the presence of U-
73122 
46 
ET-1 in the presence of 
XeC 
13 
ET-1 in the presence of U-
73122 
45 
Mouse myocytes Cell shortening 
ATP 7 
Fig 22 
ET-1 9 
ATP in the presence of 
chelerythrine 
9 
ET-1 in the presence of 
chelerythrine 
8 
LV mouse 
myocardium 
qRT-PCR 
Control 7 
Fig 23 
shRNA-IP3R2 7 
shRNA-IP3R2-EGFP 
negative mouse 
myocytes 
Ca2+ transients 
(Rhod-2) 
Tyrode 21 
Fig 24-C ATP 43 
ET-1 20 
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shRNA-IP3R2-EGFP 
positive mouse 
myocytes 
Tyrode 5 
ATP 9 
ET-1 9 
Mouse myocytes 
Current-clamp, 
Ca2+ transients 
(paired analysis) 
ATP 12 Fig 26-
B,C and 
27-B 
ET-1 10 
Thimerosal 12 
Mouse myocytes 
Current-clamp, 
Ca2+ transients 
(paired analysis) 
D-myo-Inositol 1,4,5-
trisphosphate potassium 
salt (IP3) dyalisis 
5 Fig 28-B 
Mouse myocytes 
Current-clamp, 
Ca2+ transients 
(paired analysis) 
2-APB 11 Fig 29-B 
Mouse myocytes 
Cell shortening 
(paired analysis) 
2-APB 11 Fig 29-C 
Perfused mouse 
heart 
Monophasic action 
potential (MAP) 
Control (Ctrl) 25 
Fig 31-B 
ET-1 9 
Thimerosal (Thimer) 6 
Monophasic action 
potential (MAP) 
PES protocol 
Control (Ctrl) 14 
ET-1 5 
Thimerosal (Thimer) 4 
Mouse myocytes 
Voltage-clamp, 
Ca2+ transients 
(ECC gain) 
Tyrode 15 
Fig 35-B ATP 9 
ET-1 11 
Mouse myocytes Current-clamp, ATP in the presence of 8 Fig 37-B 
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Ca2+ transients 
(paired analysis) 
ryanodine 
Mouse myocytes 
Voltage-clamp (Ni-
sensitive Current) 
Tyr in the presence of 
ryanodine 
10 
Fig 39 
ATP in the presence of 
ryanodine 
12 
ET-1 in the presence of 
ryanodine 
16 
D-myo-Inositol 1,4,5-
trisphosphate potassium 
salt (IP3) dialysis 
6 
Mouse myocytes 
Voltage-clamp, 
Ca2+ transients 
(steps and caffeine 
puffs) 
Tyrode, t=0 8 
Fig 40-B 
Tyrode, t=3-5 min 8 
Tyrode, t=7-10 min 8 
ATP/ET-1, t=0 11 
ATP/ET-1, t=3-5 min 11 
ATP/ET-1, t=7-10 min 5 
Mouse myocytes 
Current-clamp 
(paired analysis) 
ATP 5 
Fig 41-B ATP in the presence of 
thapsigargin 
5 
ET-1 7 
Fig 41-D ET-1 in the presence of 
thapsigargin 
7 
Mouse myocytes 
Current-clamp, 
(buffered [Ca2+]i, 
ATP 10 
Fig 42 
ET-1 7 
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paired analysis 
 
